MENU
JUL 22, 2021 Opens: 8:00 AM EDT

GenScript Gene & Cell Engineering Virtual Summit

Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transformed basic, translational, and biomedical research. GenScript has partnered with pioneers pushing the boundaries in gene and cell engineering by providing its deep expertise in gene synthesis technologies. This first GenScript Gene & Cell Engineering Virtual Summit will showcase cutting-edge research from leaders leveraging synthetic biology technologies in drug-discovery, de novo protein design, and genome-editing.

GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy. For more information, visit www.genscript.com


Speakers
  • Alexander Marson, MD, PhD

    Director, Gladstone-UCSF Institute of Genomic Immunology
    BIOGRAPHY
  • Gal Cafri, PhD

    Immunotherapy and Genetic Engineering Group Leader, Sheba Medical Center
    BIOGRAPHY
  • Killian S. Hanlon, PhD

    Research Fellow, Harvard Medical School; Massachusetts General Hospital
    BIOGRAPHY
  • Ben Kleinstiver, PhD

    Assistant Professor, MGH, HMS- Center for Genomic Medicine
    BIOGRAPHY
  • Ye Liu, PhD

    Senior Director of Gene Transfer Technologies, REGENXBIO Inc.
    BIOGRAPHY
  • J Joseph Melenhorst, PhD

    Professor, Pathology and Laboratory Medicine, University of Pennsylvania and Director, Biomarker Program, Parker Institute for Cancer Immunotherapy, UPenn
    BIOGRAPHY
  • Niren Murthy, PhD

    Professor, Department of Bioengineering UC Berkeley- innovative Genomics Institute
    BIOGRAPHY
  • Matthew Porteus, MD, PhD

    Professor, Stanford University, School of Medicine
    BIOGRAPHY
  • Shondra M. Pruett-Miller, PhD

    Director, St. Jude Children's Research Hospital Comprehensive Cancer Center
    BIOGRAPHY
  • Karla Camacho Soto, PhD

    Senior Scientist, Merck
    BIOGRAPHY
  • Rama Shivakumar

    Manager of Technical Applications at MaxCyte Inc.
    BIOGRAPHY
  • Sam Sternberg, PhD

    Assistant Professor, Columbia University
    BIOGRAPHY
  • Ramarao Vepachedu, PhD

    Development Scientist IV, Leidos Biomedical Research, Inc.
    BIOGRAPHY
  • John Zuris, PhD

    Associate Director, Editing Technologies at Editas Medicine
    BIOGRAPHY

Show Resources
You May Also Like
SEP 06, 2022 6:00 AM PDT
SEP 06, 2022 6:00 AM PDT
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
NOV 10, 2021 6:00 AM PST
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Twelve years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event...
NOV 09, 2022 6:00 AM PST
NOV 09, 2022 6:00 AM PST
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
APR 19, 2022 6:00 AM PDT
APR 19, 2022 6:00 AM PDT
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
MAR 23, 2022 6:00 AM PDT
MAR 23, 2022 6:00 AM PDT
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
OCT 05, 2021 1:00 AM PDT
OCT 05, 2021 1:00 AM PDT
Europe - 10:00 AM Central European Time United Kingdom - 10:00 AM British Summer Time North America - 10:00 AM Central Standard Time Lab Compliance Connect – The world’s leading...
Agenda
  • Closing Keynote Presentation          Response to Second Generation CAR T Cell Therapy: It takes (at least) Two to Tango
    JUL 22, 2021 5:00 PM EDT
    Closing Keynote Presentation Response to Second Generation CAR T Cell Therapy: It takes (at least) Two to Tango
    J Joseph Melenhorst, PhD
    Professor, Pathology and Laboratory Medicine, University of Pennsylvania and Director, Biomarker Program, Parker Institute for Cancer Immunotherapy, UPenn
    BIOGRAPHY
  • Clinical Scale Gene Editing for Cell and Gene Therapy Applications
    JUL 22, 2021 4:15 PM EDT
    Clinical Scale Gene Editing for Cell and Gene Therapy Applications
    Rama Shivakumar
    Manager of Technical Applications at MaxCyte Inc.
    BIOGRAPHY
  • Discovering the Next Generation AAV Vector Through Capsid Engineering and Expression Cassette Optimization
    JUL 22, 2021 4:15 PM EDT
    Discovering the Next Generation AAV Vector Through Capsid Engineering and Expression Cassette Optimization
    Ye Liu, PhD
    Senior Director of Gene Transfer Technologies, REGENXBIO Inc.
    BIOGRAPHY
  • "New delivery vehicles for gene editing enzymes"
    JUL 22, 2021 3:30 PM EDT
    "New delivery vehicles for gene editing enzymes"
    Niren Murthy, PhD
    Professor, Department of Bioengineering UC Berkeley- innovative Genomics Institute
    BIOGRAPHY
  • Improved chemistry by combining enzyme engineering, enzyme immobilization, and flow chemistry
    JUL 22, 2021 3:30 PM EDT
    Improved chemistry by combining enzyme engineering, enzyme immobilization, and flow chemistry
    Karla Camacho Soto, PhD
    Senior Scientist, Merck
    BIOGRAPHY
  • Library-selected AAV variants can effectively translate to non-human primates in the spinal cord and cochlea
    JUL 22, 2021 2:45 PM EDT
    Library-selected AAV variants can effectively translate to non-human primates in the spinal cord and cochlea
    Killian S. Hanlon, PhD
    Research Fellow, Harvard Medical School; Massachusetts General Hospital
    BIOGRAPHY
  • Targeted DNA integration without double-strand breaks using CRISPR RNA-guided transposons
    JUL 22, 2021 2:45 PM EDT
    Targeted DNA integration without double-strand breaks using CRISPR RNA-guided transposons
    Sam Sternberg, PhD
    Assistant Professor, Columbia University
    BIOGRAPHY
  • Operationalizing Genome Editing Across a Broad Range of Genomic and Cellular Targets
    JUL 22, 2021 1:30 PM EDT
    Operationalizing Genome Editing Across a Broad Range of Genomic and Cellular Targets
    Shondra M. Pruett-Miller, PhD
    Director, St. Jude Children's Research Hospital Comprehensive Cancer Center
    BIOGRAPHY
  • Targeted Integration in Stem Cells
    JUL 22, 2021 1:30 PM EDT
    Targeted Integration in Stem Cells
    Matthew Porteus, MD, PhD
    Professor, Stanford University, School of Medicine
    BIOGRAPHY
  • An Engineered AsCas12a nuclease facilitates the rapid generation of therapeutic cell medicines
    JUL 22, 2021 12:45 PM EDT
    An Engineered AsCas12a nuclease facilitates the rapid generation of therapeutic cell medicines
    John Zuris, PhD
    Associate Director, Editing Technologies at Editas Medicine
    BIOGRAPHY
  • CRISPR/Cas9-based genome editing for autologous CAR-T cell production
    JUL 22, 2021 12:45 PM EDT
    CRISPR/Cas9-based genome editing for autologous CAR-T cell production
    Ramarao Vepachedu, PhD
    Development Scientist IV, Leidos Biomedical Research, Inc.
    BIOGRAPHY
  • Building More Useful CRISPR-Cas Technologies
    JUL 22, 2021 12:00 PM EDT
    Building More Useful CRISPR-Cas Technologies
    Ben Kleinstiver, PhD
    Assistant Professor, MGH, HMS- Center for Genomic Medicine
    BIOGRAPHY
  • Genetic engineering approaches to support clinical applications of T-cell receptor libraries targeting oncogenic mutations
    JUL 22, 2021 12:00 PM EDT
    Genetic engineering approaches to support clinical applications of T-cell receptor libraries targeting oncogenic mutations
    Gal Cafri, PhD
    Immunotherapy and Genetic Engineering Group Leader, Sheba Medical Center
    BIOGRAPHY
  • Keynote Presentation  Reprogramming Human T Cells with CRISPR
    JUL 22, 2021 11:00 AM EDT
    Keynote Presentation Reprogramming Human T Cells with CRISPR
    Alexander Marson, MD, PhD
    Director, Gladstone-UCSF Institute of Genomic Immunology
    BIOGRAPHY
  • Track 1: Expanding CRISPR Toolbox
  • Building More Useful CRISPR-Cas Technologies
    JUL 22, 2021 12:00 PM EDT
    Building More Useful CRISPR-Cas Technologies
    Ben Kleinstiver, PhD
    Assistant Professor, MGH, HMS- Center for Genomic Medicine
    BIOGRAPHY
  • An Engineered AsCas12a nuclease facilitates the rapid generation of therapeutic cell medicines
    JUL 22, 2021 12:45 PM EDT
    An Engineered AsCas12a nuclease facilitates the rapid generation of therapeutic cell medicines
    John Zuris, PhD
    Associate Director, Editing Technologies at Editas Medicine
    BIOGRAPHY
  • Operationalizing Genome Editing Across a Broad Range of Genomic and Cellular Targets
    JUL 22, 2021 1:30 PM EDT
    Operationalizing Genome Editing Across a Broad Range of Genomic and Cellular Targets
    Shondra M. Pruett-Miller, PhD
    Director, St. Jude Children's Research Hospital Comprehensive Cancer Center
    BIOGRAPHY
  • Targeted DNA integration without double-strand breaks using CRISPR RNA-guided transposons
    JUL 22, 2021 2:45 PM EDT
    Targeted DNA integration without double-strand breaks using CRISPR RNA-guided transposons
    Sam Sternberg, PhD
    Assistant Professor, Columbia University
    BIOGRAPHY
  • "New delivery vehicles for gene editing enzymes"
    JUL 22, 2021 3:30 PM EDT
    "New delivery vehicles for gene editing enzymes"
    Niren Murthy, PhD
    Professor, Department of Bioengineering UC Berkeley- innovative Genomics Institute
    BIOGRAPHY
  • Clinical Scale Gene Editing for Cell and Gene Therapy Applications
    JUL 22, 2021 4:15 PM EDT
    Clinical Scale Gene Editing for Cell and Gene Therapy Applications
    Rama Shivakumar
    Manager of Technical Applications at MaxCyte Inc.
    BIOGRAPHY
  • Track 2: Genome Editing in Cell and Gene Therapy
  • Genetic engineering approaches to support clinical applications of T-cell receptor libraries targeting oncogenic mutations
    JUL 22, 2021 12:00 PM EDT
    Genetic engineering approaches to support clinical applications of T-cell receptor libraries targeting oncogenic mutations
    Gal Cafri, PhD
    Immunotherapy and Genetic Engineering Group Leader, Sheba Medical Center
    BIOGRAPHY
  • CRISPR/Cas9-based genome editing for autologous CAR-T cell production
    JUL 22, 2021 12:45 PM EDT
    CRISPR/Cas9-based genome editing for autologous CAR-T cell production
    Ramarao Vepachedu, PhD
    Development Scientist IV, Leidos Biomedical Research, Inc.
    BIOGRAPHY
  • Targeted Integration in Stem Cells
    JUL 22, 2021 1:30 PM EDT
    Targeted Integration in Stem Cells
    Matthew Porteus, MD, PhD
    Professor, Stanford University, School of Medicine
    BIOGRAPHY
  • Track 3: Enzyme and AAV Engineering
  • Library-selected AAV variants can effectively translate to non-human primates in the spinal cord and cochlea
    JUL 22, 2021 2:45 PM EDT
    Library-selected AAV variants can effectively translate to non-human primates in the spinal cord and cochlea
    Killian S. Hanlon, PhD
    Research Fellow, Harvard Medical School; Massachusetts General Hospital
    BIOGRAPHY
  • Improved chemistry by combining enzyme engineering, enzyme immobilization, and flow chemistry
    JUL 22, 2021 3:30 PM EDT
    Improved chemistry by combining enzyme engineering, enzyme immobilization, and flow chemistry
    Karla Camacho Soto, PhD
    Senior Scientist, Merck
    BIOGRAPHY
  • Discovering the Next Generation AAV Vector Through Capsid Engineering and Expression Cassette Optimization
    JUL 22, 2021 4:15 PM EDT
    Discovering the Next Generation AAV Vector Through Capsid Engineering and Expression Cassette Optimization
    Ye Liu, PhD
    Senior Director of Gene Transfer Technologies, REGENXBIO Inc.
    BIOGRAPHY
Speakers

  • Alexander Marson, MD, PhD
    Director, Gladstone-UCSF Institute of Genomic Immunology
    BIOGRAPHY
  • Gal Cafri, PhD
    Immunotherapy and Genetic Engineering Group Leader, Sheba Medical Center
    BIOGRAPHY
  • Killian S. Hanlon, PhD
    Research Fellow, Harvard Medical School; Massachusetts General Hospital
    BIOGRAPHY
  • Ben Kleinstiver, PhD
    Assistant Professor, MGH, HMS- Center for Genomic Medicine
    BIOGRAPHY
  • Ye Liu, PhD
    Senior Director of Gene Transfer Technologies, REGENXBIO Inc.
    BIOGRAPHY
  • J Joseph Melenhorst, PhD
    Professor, Pathology and Laboratory Medicine, University of Pennsylvania and Director, Biomarker Program, Parker Institute for Cancer Immunotherapy, UPenn
    BIOGRAPHY
  • Niren Murthy, PhD
    Professor, Department of Bioengineering UC Berkeley- innovative Genomics Institute
    BIOGRAPHY
  • Matthew Porteus, MD, PhD
    Professor, Stanford University, School of Medicine
    BIOGRAPHY
  • Shondra M. Pruett-Miller, PhD
    Director, St. Jude Children's Research Hospital Comprehensive Cancer Center
    BIOGRAPHY
  • Karla Camacho Soto, PhD
    Senior Scientist, Merck
    BIOGRAPHY
  • Rama Shivakumar
    Manager of Technical Applications at MaxCyte Inc.
    BIOGRAPHY
  • Sam Sternberg, PhD
    Assistant Professor, Columbia University
    BIOGRAPHY
  • Ramarao Vepachedu, PhD
    Development Scientist IV, Leidos Biomedical Research, Inc.
    BIOGRAPHY
  • John Zuris, PhD
    Associate Director, Editing Technologies at Editas Medicine
    BIOGRAPHY
C.E. Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Help

General Labroots Questions

email support@labroots.com  

Virtual Events and Webinars

Supported Configurations

  • Operating System Internet Explorer Firefox Chrome Safari
    Vista IE8+ FF10+ Chrome15+
    Windows 7 IE8+ FF10+ Chrome15+
    Windows 8 IE10 FF10+ Chrome15+
    Mac OS X   FF10+ Chrome15+ Safari5.1+
  • Cookie settings: session cookies enabled
  • Browser configuration must have JavaScript enabled
  • Adobe Flash player 10.2 or later

To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

Internet Connection

  • A minimum of 100Kbps is recommended for audio-only events
  • A minimum of 300Kbps is recommended for speaker on-video events

Computer Equipment

  • Screen Resolution: Minimum 1024x768
  • Video Card: 65,000 colors minimum
  • Sound card and speakers (or headphones) for hearing webcast in full format
  • Audio Card: 16-bit minimum
  • RAM: 512MB of free RAM

Firewall Protocol

  • HTTP on port 80 or HTTPS on port 443
  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

Work-At-Home Attendees

  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

For A Seamless Experience

When using a mobile device, FREE Mobile Apps are available:

- For viewing Webinars:

- For viewing Virtual Events

Attendee Guide

  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

Virtual Event and Webinar Support:

Continuing Education (CME/CE) Support

Loading Comments...
Show Resources